Anticoagulation still the baseline therapy for an acute DVT.
In recent years, we have been more aggressive in selected cases to intervene with pharmacomechanical treatments (e.g. ANGIOJET and t-PA) to achieve more rapid clearance and preserve valve
function. This is with the intent to reduce the incidence of post-phlebtic syndrome. Duration of anticoagulation depends on many factors.